UBS AM
ALAB icon

UBS AM’s Astera Labs ALAB Stock Holding History

UBS AM’s Portfolio ALAB Stock Details ALAB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$413M Buy
854,492
+205,301
+32% +$54.5M 0.08% 215
2026
Q1 		$71.2M Buy
649,191
+72,910
+13% +$10.4M 0.01% 567
2025
Q4 		$95.9M Buy
576,281
+249,158
+76% +$41.7M 0.02% 504
2025
Q3 		$64.1M Sell
327,123
-199,445
-38% -$32.8M 0.01% 560
2025
Q2 		$47.6M Buy
526,568
+394,625
+299% +$31.2M 0.01% 714
2025
Q1 		$7.87M Sell
131,943
-22,581
-15% -$2.09M ﹤0.01% 1345
2024
Q4 		$20.5M Buy
154,524
+149,240
+2,824% +$14M ﹤0.01% 938
2024
Q3 		$277K Buy
5,284
+284
+6% +$13.3K ﹤0.01% 2737
2024
Q2 		$303K Sell
5,000
-13,700
-73% -$950K ﹤0.01% 2720
2024
Q1 		$1.39M Buy
+18,700
New +$1.39M ﹤0.01% 1852

Other funds holding ALAB

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
VanEck Associates
VanEck Associates New York $164B AUM 112.45% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

UBS AM's ALAB Position: Q2 2026 in Review

UBS AM increased its Astera Labs (ALAB) stake by 32% in Q2 2026, buying an estimated $54.5M and bringing the position to 854,492 shares worth $413M. The position accounts for 0.08% of the portfolio, ranked #215.

UBS AM first reported a position in ALAB in Q1 2024 and has held it in 10 quarters since. 988 funds tracked by Wall St. Rank hold ALAB as of Q2 2026.

  • UBS AM held 854,492 shares of Astera Labs worth $413M as of Q2 2026.
  • UBS AM bought 205,301 Astera Labs shares in Q2 2026, an estimated $54.5M.
  • Astera Labs made up 0.08% of UBS AM's portfolio in Q2 2026, its #215 holding.
  • UBS AM first reported a position in Astera Labs in Q1 2024 and has held it in 10 quarters since.
  • 988 funds tracked by Wall St. Rank held Astera Labs as of Q2 2026.

Based on UBS AM's 13F filing for Q2 2026, filed 13 Aug 2026.